{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:33:11Z","timestamp":1790839991069,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.prp.2020.153025","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:32:30Z","timestamp":1590233550000},"page":"153025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer"],"prefix":"10.1016","volume":"216","author":[{"given":"Antonio","family":"Raffone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Travaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cerbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Caterina","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Insabato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2020.153025_bib0005","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.prp.2020.153025_bib0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2020.153025_bib0015","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jmig.2018.07.001","article-title":"Hysteroscopic endometrial focal resection followed by levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial Cancer: a retrospective study","volume":"26","author":"Giampaolino","year":"2019","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.prp.2020.153025_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/aogs.13553","article-title":"Management of women with atypical polypoid adenomyoma of the uterus: a quantitative systematic review","author":"Raffone","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.prp.2020.153025_bib0025","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2020.153025_bib0030","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0b013e31828c63ed","article-title":"Histotype-genotype correlation in 36 high-grade endometrial carcinomas","volume":"37","author":"Hoang","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2020.153025_bib0035","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cncr.30496","article-title":"Confirmation of ProMisE: a simple, genomics-based clinical classifier for endometrial cancer","volume":"123","author":"Talhouk","year":"2017","journal-title":"Cancer"},{"issue":"7447","key":"10.1016\/j.prp.2020.153025_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.prp.2020.153025_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41379-018-0080-0","article-title":"Nuclear \u03b2-catenin localization and mutation of the CTNNB1 gene: a context-dependent association","author":"Kim","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2020.153025_bib0050","article-title":"Immunophenotype of atypical polypoid adenomyoma of the uterus: diagnostic value and insight on pathogenesis","author":"Travaglino","year":"2019","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"1","key":"10.1016\/j.prp.2020.153025_bib0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aogs.13733","article-title":"Predictive accuracy of hormone receptors in conservatively treated endometrial hyperplasia and early endometrioid carcinoma","volume":"99","author":"Raffone","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.prp.2020.153025_bib0060","article-title":"Immunohistochemistry for BAG3 in cervical precancerous lesions","author":"Raffone","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.prp.2020.153025_bib0065","article-title":"TCGA molecular subgroups in endometrial Undifferentiated\/Dedifferentiated carcinoma","author":"Travaglino","year":"2019","journal-title":"Pathol. Oncol. Res."},{"issue":"16","key":"10.1016\/j.prp.2020.153025_bib0070","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2020.153025_bib0075","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.2015.43","article-title":"Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative","volume":"28","author":"Stelloo","year":"2015","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2020.153025_bib0080","first-page":"1622","article-title":"Overexpression and mutation of p53 in endometrial carcinoma","volume":"52","author":"Kohler","year":"1992","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2020.153025_bib0085","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004347-199710000-00010","article-title":"Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison","volume":"16","author":"Jones","year":"1997","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2020.153025_bib0090","first-page":"177","article-title":"p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis","volume":"150","author":"Tashiro","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2020.153025_bib0095","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0046-8177(98)80012-9","article-title":"Loss of p53 function in uterine papillary serous carcinoma","volume":"29","author":"Kovalev","year":"1998","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2020.153025_bib0100","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00428-005-0029-9","article-title":"Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas","volume":"447","author":"Feng","year":"2005","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.prp.2020.153025_bib0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygyno.2005.09.056","article-title":"TP53 overexpression in recurrent endometrial carcinoma","volume":"100","author":"Pijnenborg","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2020.153025_bib0110","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1158\/1078-0432.CCR-07-4837","article-title":"Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma","volume":"14","author":"Jia","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2020.153025_bib0115","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ygyno.2012.05.012","article-title":"Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt\/\u03b2-catenin and P53 pathway activation","volume":"126","author":"Nout","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2020.153025_bib0120","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/his.12581","article-title":"Targeted mutation analysis of endometrial clear cell carcinoma","volume":"66","author":"Hoang","year":"2015","journal-title":"Histopathology."},{"issue":"11","key":"10.1016\/j.prp.2020.153025_bib0125","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/modpathol.2016.132","article-title":"Molecular genetic heterogeneity in undifferentiated endometrial carcinomas","volume":"29","author":"Rosa-Rosa","year":"2016","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2020.153025_bib0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2020.153025_bib0135","article-title":"Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility","author":"K\u00f6bel","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2020.153025_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"issue":"3","key":"10.1016\/j.prp.2020.153025_bib0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/uog.15762","article-title":"Synthesizing evidence from diagnostic accuracy tests: the SEDATE guideline","volume":"47","author":"Sotiriadis","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.prp.2020.153025_bib0150","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.prp.2020.153025_bib0155","article-title":"Accuracy of one-step nucleic acid amplification in detecting lymph node metastases in endometrial Cancer","author":"Raffone","year":"2019","journal-title":"Pathol. Oncol. Res."},{"issue":"6","key":"10.1016\/j.prp.2020.153025_bib0160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/archdischild-2013-304340","article-title":"What is next generation sequencing?","volume":"98","author":"Behjati","year":"2013","journal-title":"Arch. Dis. Child. Educ. Pract. Ed."},{"issue":"3","key":"10.1016\/j.prp.2020.153025_bib0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/aogs.13513","article-title":"Loss of PTEN expression as diagnostic marker of endometrial precancer: a systematic review and meta-analysis","volume":"98","author":"Raffone","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.prp.2020.153025_bib0170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/apm.12938","article-title":"PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?","volume":"127","author":"Travaglino","year":"2019","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.prp.2020.153025_bib0175","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ajcp\/aqy178","article-title":"Immunohistochemical nuclear expression of \u03b2-Catenin as a surrogate of CTNNB1 exon 3 mutation in endometrial Cancer","volume":"151","author":"Travaglino","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.prp.2020.153025_bib0180","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00404-019-05123-x","article-title":"PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis","volume":"299","author":"Raffone","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"issue":"3","key":"10.1016\/j.prp.2020.153025_bib0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/aogs.13512","article-title":"PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia. A systematic review and meta-analysis of diagnostic accuracy","volume":"98","author":"Raffone","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"9","key":"10.1016\/j.prp.2020.153025_bib0190","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/aogs.13587","article-title":"Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review","volume":"98","author":"Travaglino","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"8","key":"10.1016\/j.prp.2020.153025_bib0195","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/aogs.13586","article-title":"Should progesterone and estrogens receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis","volume":"98","author":"Raffone","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"9","key":"10.1016\/j.prp.2020.153025_bib0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/apm.12977","article-title":"Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer","volume":"127","author":"Raffone","year":"2019","journal-title":"APMIS"},{"issue":"11","key":"10.1016\/j.prp.2020.153025_bib0205","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/apm.12988","article-title":"Nuclear expression of \u03b2-catenin in endometrial hyperplasia as marker of premalignancy","volume":"127","author":"Travaglino","year":"2019","journal-title":"APMIS"},{"issue":"2","key":"10.1016\/j.prp.2020.153025_bib0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/his.13976","article-title":"Clear cell endometrial carcinoma and the TCGA classification","volume":"76","author":"Travaglino","year":"2020","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.prp.2020.153025_bib0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/aogs.13716","article-title":"BAG3 expression correlates with the grade of dysplasia in squamous intraepithelial lesions of the uterine cervix","volume":"99","author":"Raffone","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.prp.2020.153025_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2019.08.019","article-title":"TCGA molecular groups of endometrial cancer: pooled data about prognosis","author":"Raffone","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"9213","key":"10.1016\/j.prp.2020.153025_bib0225","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.prp.2020.153025_bib0230","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/gyno.2001.6276","article-title":"Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy","volume":"82","author":"Fanning","year":"2001","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2020.153025_bib0235","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2020.153025_bib0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2020.153025_bib0245","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/AOG.0b013e3181b96ec6","article-title":"Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer?","volume":"114","author":"Kwon","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"Suppl 6","key":"10.1016\/j.prp.2020.153025_bib0250","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2020.153025_bib0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ygyno.2014.03.567","article-title":"Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer","volume":"133","author":"AlHilli","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2020.153025_bib0260","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2015.35","article-title":"Just how accurate are the major risk stratification systems for early-stage endometrial cancer?","volume":"112","author":"Bendifallah","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2020.153025_bib0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3802\/jgo.2015.26.1.32","article-title":"Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria","volume":"26","author":"Kong","year":"2015","journal-title":"J. Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2020.153025_bib0270","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/IGC.0b013e31821454f1","article-title":"Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens","volume":"21","author":"Guan","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2020.153025_bib0275","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2013.102","article-title":"Reproducibility of histological cell type in high-grade endometrial carcinoma","volume":"26","author":"Han","year":"2013","journal-title":"Mod. Pathol."},{"issue":"8","key":"10.1016\/j.prp.2020.153025_bib0280","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jcp.2005.029702","article-title":"My approach to the interpretation of endometrial biopsies and curettings","volume":"59","author":"McCluggage","year":"2006","journal-title":"J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2020.153025_bib0285","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00404-019-05299-2","article-title":"Significant risk of occult cancer in complex non-atypical endometrial hyperplasia","volume":"300","author":"Travaglino","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"issue":"5","key":"10.1016\/j.prp.2020.153025_bib0290","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00404-019-05103-1","article-title":"Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis","volume":"299","author":"Raffone","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"issue":"6","key":"10.1016\/j.prp.2020.153025_bib0295","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apm.12945","article-title":"Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia","volume":"127","author":"Travaglino","year":"2019","journal-title":"APMIS."},{"issue":"1","key":"10.1016\/j.prp.2020.153025_bib0300","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/ajcp\/aqz132","article-title":"Congruence Between 1994 WHO Classification of Endometrial Hyperplasia and Endometrial Intraepithelial Neoplasia System","volume":"153","author":"Travaglino","year":"2020","journal-title":"Am. J. Clin. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820311663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033820311663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:41:44Z","timestamp":1759732904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033820311663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0344033820311663"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.153025","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.153025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153025"}}